Injecting Drug Use and HIV/AIDS in India: An Emerging Concern

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

Scaling Up HIV Prevention among IDUs in South Asia: the key issues & gaps Dr. M. Suresh Kumar MD DPM MPH Chennai India Inter-country Consultation on Preventing.
STIGMA AND DISCRIMINATION REDUCTION AS AN ESSENTIAL PART OF COMBINATION PREVENTION Stefan Baral, MD MPH FRCPC Center for Public Health and Human Rights,
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Risk Assessment and Reduction Counselling Session 5.
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
HIV Risk Factors and HIV Prevalence Among Street Youth in Russia, Yulia Batluk, HealthRight International.
A Presentation by Dr Qazi Mujtaba Kamal National Programme Manager National AIDS Control Programme
ICTC Team Training 1 ICTC: Roles, Referrals and Linkages.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
Social Work Framework for Outreach Work Presentation 7.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Harm Reduction.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Understanding the IDU community and their vulnerabilities 1.
HIV/AIDS BI-ANNUAL REVIEW 2008 Prevention -Goal, Indicators and Targets TACAIDS.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
Female IDUs & Female Sex Partners of IDUs- Risks and Vulnerabilities 1.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Risk factors of sexually transmitted infection (STI) and their relationship with HIV among female sex workers (FSW) in Nagaland: A high HIV prevalence.
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Mobilizing for RH/HIV Integration Addis Ababa, Ethiopia Session on Technical Issues and Intersections Wednesday, February 26, 2008.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
Unit 6: Second-Generation HIV/AIDS Surveillance #1-6-1.
1 Transport against HIV/AIDS Mainstreaming the response in South Asia Jean-Noel Guillossou Focal point HIV and Transport Sustainable Department Transport.
HIV Prevention Program with Youth and KPs Implemented by PSI/Rwanda Funded by CDC.
HIV Prevention Program with Youth and KPs Implemented by PSI/Rwanda Funded by CDC.
Keeping up with the epidemic Programme success leaves us with new challenges: An evaluation of programmes for injecting sex workers.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
Session: 3 The four pronged approach to comprehensive prevention of HIV in infants and young children Dr.Pushpalatha, Assistant Professor, Dept of Pediatrics,
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
1 NTA More treatment, better treatment, fairer treatment National injecting conference Annette Dale-Perera Director of Quality.
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
Stacie M. Greby, DVM, MPH American Embassy School January 21, 2010
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
VULNERABILITY FACTORS OF SEXUALLY TRANSMISSIBLE INFECTIONS (STIs) AMONG INJECTABLE DRUG USERS (IDUs) IN MALI Dr. BORE Djibril Oral session 3 - Abstract.
#AIDS2016 HOW TO LAUNCH PROGRAMMES FOR PEOPLE WHO USE SUBSTANCES AND ARE AFFECTED BY HIV ACROSS MORE GENERALIZED HIV EPIDEMIC SETTINGS.
ACTIVITY-BASED COSTING (ABC)
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Vishwa Deepak & C. Lalsangzuala
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 1: National Data.
Maldives Last updated: September 2016.
Unit 6: Second-Generation HIV/AIDS Surveillance
Transport workers Last updated: November 2015.
Pakistan Last updated: July 2015.
Addressing Drug Use Together Through a Health Based Approach:
Addressing Vulnerability of Women IDUs in Manipur
Ehsan Mostafavi, DVM, PhD
National Survey on Extent, Pattern and Trends of Drug Abuse in India
Pauline Harvey, PhD, MSPH American Embassy School January 22, 2011
Tearing Down Fences HIV/STD Prevention in Rural America
More information is a must
Bhutan.
Myanmar Last Update: November 2014.
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
Data Hub for Asia-Pacific
Presentation transcript:

Injecting Drug Use and HIV/AIDS in India: An Emerging Concern 7 December 2004 New Delhi

The Extent, Pattern and Trends of Drug Abuse in India, National Survey Methodology The Extent, Pattern and Trends of Drug Abuse in India, National Survey National Household Survey (NHS) Drug Abuse Monitoring System (DAMS) Rapid Assessment Survey (RAS) Focused thematic studies Drug Abuse among Women Drug Abuse in Border Areas Drug Abuse in Prison Population HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Extent of IDU -- Prevalence of ever injecting NHS DAMS General population Treatment seeking (12-60) years 0.1% 14% RAS Thematic studies IDU reported in all IDU found in different fourteen sites populations (women, 43% ever injected prisoners) and in different settings (border areas) HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Drugs that are injected Heroin Propoxyphene (Spasmoproxyvon* -Dextropropoxyphene plus Dicyclomine) Buprenorphine alone or in combination with other drugs Injectable opiates like Morphine, Pethidine and Pentazocine (Fortwin*) Diazepam (Calmpose*) Promethazine (Phenargan*) Chlorpheniramine (Avil*) * The trade names mentioned do not imply a pejorative connotation HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

The switch from non-injecting to injecting Shift from inhaling vaporised heroin to injectable pharmaceuticals occur at the following times: when heroin is scarce when the cost of heroin is increasing when there is an observable reduction in purity levels when police enforcement is vigilant Easy availability and the low cost of injectable pharmaceuticals facilitate the switch to injecting. HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Direct sharing of injection equipment Non-sharing Sharing 90% 50% HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) 0% Amr Ban Trm Ahm Del Imp Kol Che Jam Shl Dim Hyd Mum

Sharing of injection equipment during the last episode of injecting Non-injectors or ex-IDUs 3,129 HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) 1,519 744 775 Current IDUs Non-sharing

Indirect sharing HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) Sharing heroin from same bottle cap (‘cooker’), Chennai

Syringe acquisition 100% Pharmacy 50% Friends 0% Amr Jam Shl Dim Hyd HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) Friends 0% Amr Jam Shl Dim Hyd Ban Trm Ahm Del Imp Che

Injecting settings Heroin injecting in a public toilet, Chennai HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) Heroin injecting in a public toilet, Chennai

Sexual behaviours among injectors "I guess my sex interest is declining. My concern is about withdrawals and I am always looking for my fix. The last time I had sex was with a sex worker two weeks ago. I was worried about becoming impotent... I wanted to test my potency... how can I attempt with my wife? It is better to try and work it with a sex worker. I did that... somehow she helped me to come through successfully. I am a bit relieved now." An IDU from Chennai HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Sexual behaviours among injectors Many drug users in Kolkata (79%) and Imphal (74%) reported sex with sex workers. Average number of non-spouse sex partners of drug users in Mumbai during the last year was three. Consistent condom use with sex workers is low. Many drug users are married. Condom use with regular sex partners is uncommon. HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

RISK RINGS HIV Clients of FSWs FSWs IDUs DRUG ABUSE AND HIV/AIDS “Feminization” of the epidemic Non-substance using sex partners of clients of sex workers Non-substance using Sex Partners of Substance users Clients of FSWs Substance Users FSWs IDUs HIV Regular Sex Partners of FSWs RISK RINGS

Major health consequences HIV/AIDS Tuberculosis STIs Abscess Overdose Hepatitis HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs) IDU-related abscess care, Chennai

Treatment-seeking behaviour among injectors A majority of drug injectors not in touch with formal services Reasons for dissatisfaction with treatment - cost - ‘felt needs’ of the drug users not addressed Many drug injectors prefer maintenance treatment with sublingual buprenorphine Treatment facilities are required for the adverse health consequences faced by IDUs HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Summary Injecting drug use is more often reported from urban areas and N.E. states Commonly injected drugs are heroin, buprenorphine, diazepam and propoxyphene; these are often used in combination High risk behaviours often accompany injecting drug use HIV infections among injecting drug users are also generally high Other adverse health consequences and drug overdoses are frequent Intervention strategies are required urgently HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Recommended interventions Reach out to drug injectors and provide services Educate the drug user Encourage drug dependence treatment Establish a hierarchy of risk reduction strategies to prevent HIV among IDUs Develop specific strategies to prevent transitions to injecting HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

Recommended interventions Strengthen peer-driven interventions Provide primary health care for drug injectors Reduce risky sexual behaviour among drug users Voluntary HIV counselling and testing Design interventions for special populations Ensure that the approach is comprehensive HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)

END HIV/AIDS-IDU nexus Triple burdens (drug use per se, HIV, HIV-related health burdens Hep, TB, opportunistic infections, abscesses etc.) Competes with scarce beds Cost of ARV ($1/day) Cost of oral substitution ($2/day) Costs of Targeted Intervention against IDU risk reduction intervention HIV/AIDS time bomb – orphans / widows – crime costs of ‘unsocialized’ street orphans (children, school drop-outs)